Clinical Trial Update: Clobazam Use in Epilepsia Partialis Continua - Pilot Study [Phase 3]

View source ↗

Summary

A Phase 3 pilot trial evaluating clobazam for Epilepsia Partialis Continua has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsia Partialis Continua
• Epilepsy
• Kojewnikov Epilepsy

Drugs mentioned

• CLOBAZAM (CLOBAZAM)

Snippet

Sponsor: The Cooper Health System | Conditions: Epilepsia Partialis Continua, Kojewnikov's Epilepsy | Phase 3 | Status: TERMINATED